Details for New Drug Application (NDA): 016832
✉ Email this page to a colleague
NDA 016832 describes CYLERT, which is a drug marketed by Abbott and is included in two NDAs. Additional details are available on the CYLERT profile page.
The generic ingredient in CYLERT is pemoline. There are seven drug master file entries for this compound. Additional details are available on the pemoline profile page.
The generic ingredient in CYLERT is pemoline. There are seven drug master file entries for this compound. Additional details are available on the pemoline profile page.
Medical Subject Heading (MeSH) Categories for 016832
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 18.75MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 37.5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 75MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
